在西班牙的一个自治区实施了第一个使用nirsevimab的呼吸道同胞细胞病毒 (RSV) 免疫接种活动
Jaime Jesús Pérez Martín1, Matilde Zornoza Moreno1
1Prevention and Health Protection Service, Ministry of Health, Murcia, Spain.
Human vaccines & immunotherapeutics
|August 13, 2024
概括
在西班牙的第一个运动中,nirsevimab有效地保护婴儿免受呼吸道同胞病毒 (RSV) 的感染,实现了高覆盖率. 该研究强调了快速免疫和成功实施未来的RSV预防策略.
科学领域:
- 儿科 儿科 儿科
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 呼吸道同胞病毒 (RSV) 是婴儿下呼吸道感染的主要原因之一.
- 单克隆抗体Nirsevimab在2023/2024赛季被引入用于婴儿RSV保护.
- 西班牙是第一个实施RSV免疫战略的国家之一.
研究的目的:
- 评估西班牙最初的尼尔塞维马布免疫接种活动的结果.
- 分析免疫婴儿群体的特征.
- 为西班牙和其他国家的未来RSV预防战略提供信息.
主要方法:
- 从2023/2024赛季对nirsevimab免疫数据的回顾性分析.
- 在运动期间和之前出生的婴儿免疫覆盖率的计算.
- 根据健康状况和原产地,分析免疫接种时间和免疫接种年龄.
主要成果:
- 实现了高免疫覆盖率:91.5%的婴儿出生在这个季节和88.3%的总体.
- 季节出生婴儿在产科医院的拒绝率低 (4.9%),平均延迟 27.45 天.
- 在移民人口中观察到覆盖率较低;在追赶婴儿 (15.63天) 中观察到快速免疫速度.
- 健康的婴儿比那些有风险状况的婴儿在较年轻时获得免疫,无论是在运动期间还是在运动之前出生的人.
结论:
- 在西班牙穆尔西亚地区的第一个nirsevimab免疫接种活动非常成功.
- 该战略表明,在婴儿中有效预防RSV,覆盖率高,吸收速度快.
- 研究结果为规划和优化未来的国家RSV免疫计划提供了宝贵的见解.
相关概念视频
Vaccinations
Overview
Common Respiratory Disorders
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...


